Clinical trials
Staging clinical trials
Below are recruiting staging clinical trials, each written for real people, not researchers. We’re tracking 1,885 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06860815RecruitingPhase 2
Cemiplimab with liver radiation for breast cancer that spread to the liver
This trial tests a combination of a drug called cemiplimab (an immunotherapy that helps your immune system fight cancer) and a type of targeted radiation (Y-90 SIR-Spheres) given directly to liver tumors. It is for people with breast cancer that has spread to the liver and who have already had at least one type of chemotherapy.
Duarte, CaliforniaAges 18 years+ - NCT06861283Recruiting
Digital twin health study for community patients
This study is testing a digital system that creates a virtual model of your health to help doctors provide better care. It is designed for people who receive care at a community health center and are willing to follow the study procedures.
Wuxi, JiangsuAges 18 years+ - NCT06861816Recruiting
Walking with dogs for teens on dialysis
This study looks at whether a program of walking with dogs can help teenagers on dialysis breathe easier and feel less tired. It focuses on how the program might improve your lungs and your ability to be active.
Dokki, Giza GovernorateAges 13–17 - NCT06868888Recruiting
Red blood cell function in kidney failure
This study looks at how red blood cells work in people with end-stage kidney disease who are on hemodialysis. It aims to understand blood flow and may help guide future treatments.
TaoyuanAges 20 years+ - NCT06871176Recruiting
New PET/MR scan vs standard imaging for multiple myeloma
This trial compares a new type of PET/MR scan (using a radioactive tracer called Ga-68 PentixaFor) with standard imaging to see if it can better detect multiple myeloma at diagnosis and during follow-up. It may help improve staging and treatment planning.
Toronto, OntarioAges 18 years+ - NCT06877065Recruiting
MRI-Guided Fertility Preservation for Cervical Cancer
This study uses MRI scans to see if women with early-stage cervical cancer can safely keep their fertility. It follows patients before and after treatment to find which factors might lead to more aggressive disease.
RomeAges 18 years+ - NCT06877299RecruitingPhase 2
Combination Therapy for Stage IIA-IIIB Lung Cancer
This trial tests a combination of low-dose radiation, focused high-dose radiation (SBRT), chemotherapy, and an immunotherapy drug (tislelizumab) for people with stage IIA to IIIB non-small cell lung cancer that hasn't been treated yet. The goal is to see if this approach can help shrink tumors and improve outcomes before or instead of surgery.
Chengdu, ChinaAges 18–75 - NCT06878560RecruitingPhase 1/Phase 2
Pig kidney transplant for kidney failure patients
This trial tests a special pig kidney (10 GE Xenokidney) as a transplant option for people with kidney failure who cannot get a human kidney. It aims to offer a life-saving alternative.
Chicago, IllinoisAges 40–70 - NCT06879730Recruiting
Studying surgery types for early-stage ovarian cancer
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
Varese, VareseAges Any age - NCT06889688RecruitingPhase 3
New drug combo vs. chemo for advanced triple-negative breast cancer
This trial tests a new combination of three drugs (camrelizumab, apatinib, and eribulin) against the standard chemotherapy chosen by your doctor. It's for people with advanced triple-negative breast cancer that has gotten worse after previous treatments.
Guangzhou, GuangdongAges 18–70 - NCT06896474Recruiting
Breast cancer treatment choice help for women 70 and older
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
Los Angeles, CaliforniaAges 18 years+ - NCT06899919Recruiting
Light compression wrap for mixed leg ulcers
This trial tests a light compression system for mixed leg ulcers, which are wounds on the lower leg that have both vein and artery problems. It may help you if you have this type of wound that is not too large or too old.
Paris, ParisAges 18 years+ - NCT06903559RecruitingPhase 1/Phase 2
Roxadustat for heart and nutrition in dialysis patients
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
Al Mansurah, DakahliyaAges 18 years+ - NCT06905145Recruiting
Molecular testing for advanced head and neck cancer
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
NaplesAges 18 years+ - NCT06905301Recruiting
Study on breast cancer medication with a mobile app
This study compares how well breast cancer patients take their medication (ribociclib) with or without using a mobile app. It aims to see if the app helps patients stick to their treatment plan.
Pskov, RussiaAges 18–90 - NCT06906874RecruitingPhase 2
Activated charcoal for kidney disease patients on dialysis
This trial tests if taking activated charcoal by mouth can help people with advanced kidney disease who are already on dialysis. It may improve how the body handles certain waste products and reduce the need for other medicines.
Al Mansurah, Please SelectAges 18 years+ - NCT06908070RecruitingPhase 4
Chemoradiation, surgery, then durvalumab for stage 3 lung cancer
This trial tests if giving the immunotherapy drug durvalumab after chemoradiation and surgery helps people with stage 3 non-small cell lung cancer. You will receive standard chemoradiation, then have surgery, and then get durvalumab to see if it lowers the chance of the cancer coming back.
AmsterdamAges 18 years+ - NCT06911333RecruitingPhase 1/Phase 2
A new drug for advanced solid tumors that have stopped responding to treatment
This trial tests a new drug called AD1208 for people with advanced solid tumors that have grown despite previous treatments. The goal is to see if the drug can help where other options no longer work or are not suitable.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT06911528Recruiting
New cell-probing technology for early breast cancer surgery
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06913647RecruitingPhase 2
Canagliflozin for fluid removal and health in peritoneal dialysis patients
This trial tests if canagliflozin, a diabetes medicine, helps remove extra fluid and reduce scarring in people on peritoneal dialysis (home-based dialysis). It may improve your dialysis results and protect your belly lining.
Montreal, QuebecAges 18 years+ - NCT06914596Recruiting
Comparing an at-home gum treatment to standard care after deep cleaning
This study tests if a device you use at home for 30 minutes twice a day can improve gum healing after a deep cleaning (scaling and root planing). Participants will have their gum health compared to a group that receives standard care.
Fullerton, CaliforniaAges 30–75 - NCT06916507Recruiting
Early Use of a Parkinson's Pump in Advanced Stages
This study tests a new pump-delivered combination of Parkinson's medications (foslevodopa/foscarbidopa) in adults who have recently started having motor fluctuations but are not yet using other device therapies. It aims to see how well it works in real life and may offer better symptom control.
Heidelberg, Baden-WurttembergAges 18–64 - NCT06917950RecruitingPhase 1/Phase 2
Roxadustat for bone and brain health in dialysis patients
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Al Mansurah, DakahliyaAges 18 years+ - NCT06925217Recruiting
Closed-loop insulin for type 2 diabetes and kidney disease
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
Lausanne, Canton of VaudAges 18 years+
Hear when a new Staging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for staging?
- Yes. Clin2 currently lists 1,885 recruiting staging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a staging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a staging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.